$0.1340
At close: Apr 17, 4:00 PM EDT
$0.1075
-0.03-19.78%
After Hours: Apr 10, 8:00 AM EDT
Track the latest T2 Biosystems insider trading activity. Stay informed on recent buys, sells, and market impact for T2 Biosystems stock.
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
Insiders have report no purchases/sales in the last 30 days.
There has been no Insider buying or selling in the last 90 days.
Sep 17, 2024 | David Elsbree | — | -55.00 | $2.42 | -$133.10 | SELL | -68.75% | 25.00 | Sep 13 | View |
Sep 29, 2023 | CR Group LPCRG Partners III LPCRG Partners III Parallel Fund A LPCRG Partners III Cayman Unlev AIV I LPCRG Partners III Cayman Lev AIV I LP | 10% OWNER | -13.13M | $0.17 | -$2.27M | SELL | -100.00% | 0.00 | Sep 27 - Sep 28 | View |
Sep 28, 2023 | CR Group LPCRG Partners III LPCRG Partners III Parallel Fund A LPCRG Partners III Cayman Unlev AIV I LPCRG Partners III Cayman Lev AIV I LP | 10% OWNER | -5.39M | $0.20 | -$1.08M | SELL | -60.24% | 3.56M | Sep 26 | View |
Sep 27, 2023 | CR Group LPCRG Partners III LPCRG Partners III Parallel Fund A LPCRG Partners III Cayman Unlev AIV I LPCRG Partners III Cayman Lev AIV I LP | 10% OWNER | -250.00K | $0.25 | -$62.50K | SELL | -4.74% | 5.02M | Sep 25 | View |
Sep 26, 2023 | CR Group LPCRG Partners III LPCRG Partners III Parallel Fund A LPCRG Partners III Cayman Unlev AIV I LPCRG Partners III Cayman Lev AIV I LP | 10% OWNER | -5.08M | $0.26 | -$1.31M | SELL | -49.95% | 5.09M | Sep 22 | View |
Sep 25, 2023 | CR Group LPCRG Partners III LPCRG Partners III Parallel Fund A LPCRG Partners III Cayman Unlev AIV I LPCRG Partners III Cayman Lev AIV I LP | 10% OWNER | -6.34M | $0.30 | -$1.90M | SELL | -49.50% | 6.47M | Sep 21 | View |
Sep 22, 2023 | CR Group LPCRG Partners III LPCRG Partners III Parallel Fund A LPCRG Partners III Cayman Unlev AIV I LPCRG Partners III Cayman Lev AIV I LP | 10% OWNER | -7.75M | $0.31 | -$2.41M | SELL | -48.65% | 8.18M | Sep 20 | View |
Sep 21, 2023 | CR Group LPCRG Partners III LPCRG Partners III Parallel Fund A LPCRG Partners III Cayman Unlev AIV I LPCRG Partners III Cayman Lev AIV I LP | 10% OWNER | -10.40M | $0.37 | -$3.81M | SELL | -50.28% | 10.29M | Sep 19 | View |
Apr 06, 2023 | Terrence Michael Gibbs | GENERAL COUNSEL | -239.00 | $0.48 | -$114.96 | SELL | -3.49% | 6.61K | Mar 28 | View |
Mar 09, 2023 | Brett Giffin | CHIEF COMMERCIAL OFFICER | 796.00 | $0.65 | -$349.05 | SELL-OPTIONS | 1768.89% | 841.00 | Feb 20 - Feb 22 | View |
Mar 09, 2023 | John Sprague Attorney-in-fact | CHIEF FINANCIAL OFFICER | 4.22K | $0.62 | -$1.68K | SELL-OPTIONS | 138.53% | 7.27K | Feb 20 - Feb 28 | View |
Mar 09, 2023 | Terrence Michael Gibbs | GENERAL COUNSEL | 3.18K | $0.62 | -$2.33K | SELL-OPTIONS | 95.53% | 6.52K | Feb 20 - Feb 28 | View |
Mar 09, 2023 | John Sperzel III | CHAIRMAN AND CEO | 12.89K | $0.63 | -$6.18K | SELL-OPTIONS | 290.73% | 17.33K | Feb 20 - Feb 28 | View |
Nov 22, 2022 | Brett Giffin | CHIEF COMMERCIAL OFFICER | 2.04K | $1.79 | -$2.32K | SELL-OPTIONS | 962.74% | 2.25K | Nov 08 - Nov 10 | View |
Apr 11, 2022 | John Sperzel III | CHAIRMAN, CEO, AND PRESIDENT | 30.00K | $0.50 | $15.00K | BUY | 15.64% | 221.77K | Apr 07 | View |
Apr 11, 2022 | Alec Barclay | CHIEF OPERATIONS OFFICER | 12.95K | $0.50 | $6.48K | BUY | 7.66% | 181.94K | Apr 08 | View |
Apr 11, 2022 | Terrence Michael Gibbs | GENERAL COUNSEL | 10.00K | $0.49 | $4.90K | BUY | 6.38% | 166.65K | Apr 07 | View |
Apr 11, 2022 | John Sprague | CHIEF FINANCIAL OFFICER | 10.00K | $0.48 | $4.77K | BUY | 7.02% | 152.35K | Apr 08 | View |
Apr 11, 2022 | Brett Giffin | CHIEF COMMERCIAL OFFICER | 10.60K | $0.49 | $5.18K | BUY | ∞ | 10.60K | Apr 08 | View |
Jan 10, 2022 | Aparna Ahuja | CHIEF MEDICAL OFFICER | -61.99K | $0.48 | -$29.75K | SELL | -36.55% | 107.61K | Jan 06 | View |
Aug 03, 2021 | GOLDMAN SACHS CO LLCGOLDMAN SACHS GROUP INC | 10% OWNER | 5.13K | $0.63 | $4.12K | BUY | 0.12% | 4.20M | Mar 24 - May 20 | View |
Aug 03, 2021 | Adrian Jones | DIRECTOR | 5.13K | $0.63 | $4.12K | BUY | 0.12% | 4.20M | Mar 24 - May 20 | View |
Jul 02, 2021 | John Sprague Attorney-in-Fact | DIRECTOR | -18.18K | $1.16 | -$21.09K | SELL | -3.40% | 516.39K | Jul 01 | View |
Jul 02, 2021 | JOHN CUMMING | DIRECTOR | -18.18K | $1.16 | -$21.09K | SELL | -26.34% | 50.85K | Jul 01 | View |
Mar 25, 2021 | Terrence Michael Gibbs | GENERAL COUNSEL | 7.91K | $1.56 | -$13.66K | SELL-OPTIONS | 12.10% | 73.26K | Mar 24 - Mar 25 | View |
Mar 18, 2021 | Alec Barclay | CHIEF OPERATIONS OFFICER | -12.49K | $1.86 | -$23.24K | SELL | -14.38% | 74.42K | Mar 17 | View |
Mar 18, 2021 | Anthony Pare | CHIEF COMMERCIAL OFFICER | -9.62K | $1.84 | -$17.70K | SELL | -23.33% | 31.61K | Mar 17 | View |
Feb 23, 2021 | Terrence Michael Gibbs | GENERAL COUNSEL | 2.72K | $2.06 | -$15.00K | SELL-OPTIONS | 4.34% | 65.35K | Feb 21 - Feb 23 | View |
Feb 23, 2021 | John Sprague Attorney-in-fact | CHIEF FINANCIAL OFFICER | 4.75K | $2.04 | -$10.71K | SELL-OPTIONS | 15.45% | 35.48K | Feb 21 - Feb 23 | View |
Feb 23, 2021 | Alec Barclay | CHIEF OPERATIONS OFFICER | 2.72K | $2.06 | -$15.00K | SELL-OPTIONS | 4.35% | 65.25K | Feb 21 - Feb 23 | View |
Browse insider trades on all stocks.